InvestorsHub Logo

seventhwave

10/13/17 12:23 AM

#124402 RE: F1ash #124399

Daniela Semedo was completely off her rocker in writing that - a case of very poor DD. I would expect you to have dismissed it off the bat without blinking and not spent an extra second thinking about it again. Perry's case is cringeworthy and I hope you can estab. contact.
And of course we have 7 remaining who have improved MMSE scores at 12 months. So an equivalent ~20%/ITT to Flurizipan. It hasn't been in contention to my knowledge (I don't read every post.)

ohsaycanyousee82

10/13/17 1:42 AM

#124409 RE: F1ash #124399

Wow! His statement made you “cringe”. Interesting choice of words. Cringe seems to imply pain. And as a neutral observer of Anavex developments, to extend yourself and to reach out to him to set the record straight is rather stunning. Truly admirable.

ExtremelyBullishZig

10/13/17 7:13 AM

#124427 RE: F1ash #124399

Maybe he was referring to the type of improvement and which areas were improved.